首页 > 最新文献

Onkologie (Czech Republic)最新文献

英文 中文
Trifluridine/tipiracil treatment in a patient with mucinous metastatic colorectal carcinoma 曲氟定/替吡拉西治疗黏液转移性结直肠癌1例
Q4 Medicine Pub Date : 2022-08-24 DOI: 10.36290/xon.2022.041
J. Švec, V. Kořínek, R. Soumarová
Trifluridine/tipiracil treatment
Trifluridine / tipiracil治疗
{"title":"Trifluridine/tipiracil treatment in a patient with mucinous metastatic colorectal carcinoma","authors":"J. Švec, V. Kořínek, R. Soumarová","doi":"10.36290/xon.2022.041","DOIUrl":"https://doi.org/10.36290/xon.2022.041","url":null,"abstract":"Trifluridine/tipiracil treatment","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44232471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Genetic testing in ovarian cancer 癌症基因检测
Q4 Medicine Pub Date : 2022-08-24 DOI: 10.36290/xon.2022.037
J. Soukupová
, genetic testing of germline mutations allows targeted genetic counselling in the patient`s family, identification of individuals at risk and appropriate surveillance management of the patient and her positively tested healthy relatives. Germline as well as somatic mutations in BRCA1 and BRCA2 genes may also play a role in the consideration of the indication of a specific poly-ADP-ribose polymerase inhibitor (PARPi). Somatic mutations in BRCA1 and BRCA2 are found in an additional 5–9% of women with ovarian cancer. Simultaneous testing for germline and somatic mutations will allow for more efficient identification of patients who are potential candidates for one type of PARPi maintenance therapy, while also detecting healthy relatives at high risk of developing breast and ovarian cancer in particular.
,种系突变的基因检测可以为患者的家庭提供有针对性的基因咨询,识别有风险的个体,并对患者及其检测呈阳性的健康亲属进行适当的监测管理。BRCA1和BRCA2基因的种系和体细胞突变也可能在考虑特异性聚ADP核糖聚合酶抑制剂(PARPi)的适应症中发挥作用。BRCA1和BRCA2的体细胞突变在另外5-9%的癌症女性中发现。种系和体细胞突变的同时检测将有助于更有效地识别一种PARPi维持治疗的潜在候选患者,同时也能检测出特别是乳腺癌和卵巢癌癌症高风险的健康亲属。
{"title":"Genetic testing in ovarian cancer","authors":"J. Soukupová","doi":"10.36290/xon.2022.037","DOIUrl":"https://doi.org/10.36290/xon.2022.037","url":null,"abstract":", genetic testing of germline mutations allows targeted genetic counselling in the patient`s family, identification of individuals at risk and appropriate surveillance management of the patient and her positively tested healthy relatives. Germline as well as somatic mutations in BRCA1 and BRCA2 genes may also play a role in the consideration of the indication of a specific poly-ADP-ribose polymerase inhibitor (PARPi). Somatic mutations in BRCA1 and BRCA2 are found in an additional 5–9% of women with ovarian cancer. Simultaneous testing for germline and somatic mutations will allow for more efficient identification of patients who are potential candidates for one type of PARPi maintenance therapy, while also detecting healthy relatives at high risk of developing breast and ovarian cancer in particular.","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42330561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Treatment of a senior patient with cardiovascular comorbidities using checkpoint inhibitor therapy 使用检查点抑制剂治疗一名患有心血管合并症的老年患者
Q4 Medicine Pub Date : 2022-08-24 DOI: 10.36290/xon.2022.040
K. Hrušák, T. Büchler, J. Votrubova
{"title":"Treatment of a senior patient with cardiovascular comorbidities using checkpoint inhibitor therapy","authors":"K. Hrušák, T. Büchler, J. Votrubova","doi":"10.36290/xon.2022.040","DOIUrl":"https://doi.org/10.36290/xon.2022.040","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41466250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New potential checkpoint inhibitors in cancer therapy 癌症治疗中新的潜在检查点抑制剂
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.022
J. Kopecký
{"title":"New potential checkpoint inhibitors in cancer therapy","authors":"J. Kopecký","doi":"10.36290/xon.2022.022","DOIUrl":"https://doi.org/10.36290/xon.2022.022","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43846637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy for the treatment of metastatic uveal melanoma 免疫疗法治疗转移性葡萄膜黑色素瘤
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.026
J. Podhorec, R. Lakomy, A. Poprach, I. Kiss
{"title":"Immunotherapy for the treatment of metastatic uveal melanoma","authors":"J. Podhorec, R. Lakomy, A. Poprach, I. Kiss","doi":"10.36290/xon.2022.026","DOIUrl":"https://doi.org/10.36290/xon.2022.026","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41649549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemoresistant myeloid sarcoma responding to salvage therapy with combined azacitidine and venetoclax 阿扎胞苷联合venetoclax挽救化疗耐药髓系肉瘤疗效观察
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.030
M. Hisemová, V. Ptáčník
{"title":"Chemoresistant myeloid sarcoma responding to salvage therapy with combined azacitidine and venetoclax","authors":"M. Hisemová, V. Ptáčník","doi":"10.36290/xon.2022.030","DOIUrl":"https://doi.org/10.36290/xon.2022.030","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49440844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immunotherapy in non-melanoma skin cancer 非黏液瘤皮肤癌症的免疫治疗
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.027
Miroslav Důra
{"title":"Immunotherapy in non-melanoma skin cancer","authors":"Miroslav Důra","doi":"10.36290/xon.2022.027","DOIUrl":"https://doi.org/10.36290/xon.2022.027","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42322625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy in upper gastrointestinal malignancies 上消化道恶性肿瘤的免疫治疗
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.024
M. Žiaran
{"title":"Immunotherapy in upper gastrointestinal malignancies","authors":"M. Žiaran","doi":"10.36290/xon.2022.024","DOIUrl":"https://doi.org/10.36290/xon.2022.024","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47330310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The issue of assessing the degree of dependence for the purposes of the care allowance for people with cancer 为癌症患者护理津贴目的评估依赖程度的问题
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.028
L. Čeledová, R. Čevela
{"title":"The issue of assessing the degree of dependence for the purposes of the care allowance for people with cancer","authors":"L. Čeledová, R. Čevela","doi":"10.36290/xon.2022.028","DOIUrl":"https://doi.org/10.36290/xon.2022.028","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43123560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy for patients with pancreatic adenocarcinoma 胰腺腺癌患者的免疫治疗
Q4 Medicine Pub Date : 2022-05-16 DOI: 10.36290/xon.2022.025
S. John
{"title":"Immunotherapy for patients with pancreatic adenocarcinoma","authors":"S. John","doi":"10.36290/xon.2022.025","DOIUrl":"https://doi.org/10.36290/xon.2022.025","url":null,"abstract":"","PeriodicalId":38365,"journal":{"name":"Onkologie (Czech Republic)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42086345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Onkologie (Czech Republic)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1